• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过互补决定区(CDR)移植和特异性决定残基移植实现人源化。

Humanization by CDR grafting and specificity-determining residue grafting.

作者信息

Kim Jin Hong, Hong Hyo Jeong

机构信息

Department of Systems Immunology, College of Biomedical Science, Kangwon National University, Gangwon-do, Korea.

出版信息

Methods Mol Biol. 2012;907:237-45. doi: 10.1007/978-1-61779-974-7_13.

DOI:10.1007/978-1-61779-974-7_13
PMID:22907355
Abstract

Humanized antibodies are constructed by CDR grafting, while retaining those murine framework residues that influence the antigen-binding activity. To reduce the immunogenicity of CDR-grafted humanized antibodies, the murine content in the CDR-grafted humanized antibodies is minimized through SDR grafting. Within each CDR, there are more variable positions that are directly involved in the interaction with antigen, i.e., specificity-determining residues (SDRs), whereas there are more conserved residues that maintain the conformations of CDRs loops. SDRs may be identified from the 3D structure of the antigen-antibody complex and/or the mutational analysis of the CDRs. An SDR-grafted humanized antibody is constructed by grafting the SDRs and the residues maintaining the conformations of the CDRs onto human template, and its immunogenic potential is evaluated by measuring the reactivity to the sera from patients who had been immunized with the parental antibody.

摘要

人源化抗体通过互补决定区(CDR)移植构建,同时保留那些影响抗原结合活性的鼠源框架残基。为降低CDR移植人源化抗体的免疫原性,通过超变区(SDR)移植将CDR移植人源化抗体中的鼠源成分降至最低。在每个CDR内,有更多直接参与与抗原相互作用的可变位置,即特异性决定残基(SDR),而有更多保守残基维持CDR环的构象。SDR可从抗原-抗体复合物的三维结构和/或CDR的突变分析中鉴定出来。通过将SDR和维持CDR构象的残基移植到人源模板上构建SDR移植人源化抗体,并通过测量其对用亲本抗体免疫的患者血清的反应性来评估其免疫原性潜力。

相似文献

1
Humanization by CDR grafting and specificity-determining residue grafting.通过互补决定区(CDR)移植和特异性决定残基移植实现人源化。
Methods Mol Biol. 2012;907:237-45. doi: 10.1007/978-1-61779-974-7_13.
2
SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.使用多种人类种系模板对鼠源抗体进行SDR移植,以尽量降低其免疫原性。
Mol Immunol. 2004 Jul;41(9):863-72. doi: 10.1016/j.molimm.2004.03.041.
3
SDR grafting--a new approach to antibody humanization.SDR移植——抗体人源化的一种新方法。
Methods. 2005 May;36(1):25-34. doi: 10.1016/j.ymeth.2005.01.003.
4
Construction of a humanized antibody to hepatitis B surface antigen by specificity-determining residues (SDR)-grafting and de-immunization.通过特异性决定残基(SDR)-嫁接和去免疫化构建人源抗乙型肝炎表面抗原抗体。
Biochem Biophys Res Commun. 2010 May 28;396(2):231-7. doi: 10.1016/j.bbrc.2010.04.071. Epub 2010 Apr 23.
5
Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.通过对接近受体框架的互补决定区残基进行重新设计来实现抗体人源化。
Methods. 2014 Jan 1;65(1):68-76. doi: 10.1016/j.ymeth.2013.06.024. Epub 2013 Jun 28.
6
Minimizing the immunogenicity of antibodies for clinical application.将抗体的免疫原性降至最低以用于临床应用。
Tumour Biol. 2005 Jan-Feb;26(1):31-43. doi: 10.1159/000084184.
7
Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.通过同时优化框架区和互补决定区残基对鼠单克隆抗体进行人源化。
J Mol Biol. 1999 Nov 19;294(1):151-62. doi: 10.1006/jmbi.1999.3141.
8
Antibody humanization methods - a review and update.抗体人源化方法 - 综述与更新。
Biotechnol Genet Eng Rev. 2013;29:175-86. doi: 10.1080/02648725.2013.801235. Epub 2013 Aug 2.
9
Humanization of an anti-CD34 monoclonal antibody by complementarity-determining region grafting based on computer-assisted molecular modelling.基于计算机辅助分子建模的互补决定区移植法对一种抗CD34单克隆抗体进行人源化改造。
J Biochem. 2008 Jul;144(1):115-20. doi: 10.1093/jb/mvn052. Epub 2008 Apr 19.
10
Comparison of "framework Shuffling" and "CDR Grafting" in humanization of a PD-1 murine antibody.比较“框架重排”和“CDR 移植”在 PD-1 鼠抗体人源化中的作用。
Front Immunol. 2024 Jul 15;15:1395854. doi: 10.3389/fimmu.2024.1395854. eCollection 2024.

引用本文的文献

1
Advancements in antibody-drug conjugates as cancer therapeutics.抗体药物偶联物作为癌症治疗手段的进展。
J Natl Cancer Cent. 2025 Apr 19;5(4):362-378. doi: 10.1016/j.jncc.2025.01.007. eCollection 2025 Aug.
2
Design of nanobody targeting SARS-CoV-2 spike glycoprotein using CDR-grafting assisted by molecular simulation and machine learning.利用分子模拟和机器学习辅助的互补决定区嫁接设计靶向严重急性呼吸综合征冠状病毒2刺突糖蛋白的纳米抗体
PLoS Comput Biol. 2025 Apr 21;21(4):e1012921. doi: 10.1371/journal.pcbi.1012921. eCollection 2025 Apr.
3
50 Years of Antibody Numbering Schemes: A Statistical and Structural Evaluation Reveals Key Differences and Limitations.
抗体编号方案50年:统计与结构评估揭示关键差异和局限性
Antibodies (Basel). 2024 Dec 4;13(4):99. doi: 10.3390/antib13040099.
4
Engineering and characterization of Hu3A4: A novel humanized antibody with potential as a therapeutic agent against myeloid lineage leukemias.Hu3A4的工程化与特性研究:一种具有治疗髓系白血病潜力的新型人源化抗体。
Neoplasia. 2025 Jan;59:101084. doi: 10.1016/j.neo.2024.101084. Epub 2024 Nov 20.
5
Matrixed CDR grafting: A neoclassical framework for antibody humanization and developability.基质化 CDR 嫁接:抗体人源化和可开发性的新古典框架。
J Biol Chem. 2024 Jan;300(1):105555. doi: 10.1016/j.jbc.2023.105555. Epub 2023 Dec 10.
6
Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines.指导抗体治疗药物和疫苗设计的结构与动力学
Antibodies (Basel). 2023 Oct 18;12(4):67. doi: 10.3390/antib12040067.
7
Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery.机器设计的生物疗法:深度学习在计算性抗体发现中的机会、可行性和优势。
Brief Bioinform. 2022 Jul 18;23(4). doi: 10.1093/bib/bbac267.
8
Nanobody-based CAR-T cells for cancer immunotherapy.用于癌症免疫治疗的基于纳米抗体的嵌合抗原受体T细胞。
Biomark Res. 2022 Apr 25;10(1):24. doi: 10.1186/s40364-022-00371-7.
9
Immune Regulatory 1 Cells: A Novel and Potent Subset of Human T Regulatory Cells.免疫调节 1 细胞:一种新型且有效的人类 T 调节细胞亚群。
Front Immunol. 2022 Feb 8;12:790775. doi: 10.3389/fimmu.2021.790775. eCollection 2021.
10
Humanized Chimeric Antigen Receptor (CAR) T cells.人源化嵌合抗原受体(CAR)T细胞。
J Cancer Immunol (Wilmington). 2021;3(4):183-187.